InnovaHealth Partners

InnovaHealth Partners is a New York City-based investment firm specializing in growth buyouts of established medical technology companies. The firm focuses on high-growth sectors within the medical device industry, partnering with exceptional management teams to build innovative, differentiated, and high-growth companies. Their investments address large unmet surgical needs on a global scale, aiming to enhance patient outcomes and improve healthcare results sustainably.

The firm's strategy involves targeting medical technology companies with innovative products that address significant clinical needs, primarily in the United States, Europe, and Israel. InnovaHealth Partners seeks to acquire controlling positions in its portfolio companies as the sole or lead investor. Beyond capital, the firm collaborates with management teams to accelerate growth and value creation, leveraging longstanding relationships with strategic acquirers, clinical and scientific advisors, regulatory and reimbursement experts, and industry executives.

InnovaHealth Partners has a strong track record of successful investments in the medical device sector. Notable portfolio companies include Koelis, a leader in image-guided systems for prostate cancer diagnosis and treatment; Radiaction, which offers an automated system that substantially reduces radiation dose for physicians and technicians in interventional treatment suites; and Channel Medsystems, an innovative women's health company that offers an FDA-approved endometrial ablation device to treat heavy menstrual bleeding. These investments reflect the firm's commitment to advancing patient care through innovative medical technologies.